Gender Dysphoria is the feeling of discomfort or distress that might occur in people whose gender identity differs from their sex assigned at birth or sex-related physical characteristics. In 2017, the therapeutic market of Gender Dysphoria in 7MM was USD 102.73 million. As per the Delveinsight, the total prevalent population of Gender Dysphoria in the 7MM was 37,241 in 2017. The prevalence of Gender Dysphoria in the United States was found to be 12,521, while the UK and France had a prevalence of 8,214 and 1,544, respectively. The absence of therapies in the market, increase in the affected population, poor efficacy, and side effects associated with current therapies are some of the key factors expected to drive the Gender Dysphoria market forward in the coming years. Source: Gender Dysphoria Market